Cargando…
Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy
Liquid biopsy, based on the circulating tumor cells (CTCs) and cell-free nucleic acids has potential applications at multiple points throughout the natural course of cancer, from diagnosis to follow-up. The advantages of doing ctDNA assessment vs. tissue-based genomic profile are the minimal procedu...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407029/ https://www.ncbi.nlm.nih.gov/pubmed/30736478 http://dx.doi.org/10.3390/cancers11020196 |